RxDoctor Payments Data

Cas Cader, MD

Family Medicine · Morehead City, NCNPI 1356376503

Payments from drug & device makers

$9,884in general payments, 2019–2025

Across 661 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Amgen$1K
  • GSK$827
  • Pfizer$651
  • Lilly USA, LLC$579
  • plus $4K from 52 others

What the payments were for

  • Food & beverage$9,879100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)95$1,293
Novo Nordisk97$1,176
Amgen85$1,111
GSK52$827
Pfizer54$651
Lilly USA, LLC48$579
AstraZeneca17$475
Abbott16$379
Sanofi-aventis U.S. LLC18$279
Merck17$262
Preventric Diagnostics, Inc.1$223
Boehringer Ingelheim14$219
Bayer12$208
Takeda Pharmaceuticals U.S.A., Inc.14$199
Kowa Pharmaceuticals America, Inc.10$136
Otsuka America Pharmaceutical, Inc.7$122
Astellas Pharma US Inc8$114
Daiichi Sankyo Inc.7$99
Lundbeck LLC4$99
Exact Sciences6$95
Phathom Pharmaceuticals, Inc.5$93
Amarin Pharma, Inc.6$80
Radius Health, Inc.4$76
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$69
Novartis4$66
Johnson & Johnson5$65
Biohaven Pharmaceuticals, Inc.3$59
Almatica Pharma LLC4$59
Baxter Healthcare1$58
Eisai Inc.4$54
Arbor Pharmaceuticals, Inc.4$53
Intra-sana Laboratories3$51
Biohaven Pharmaceutical Holding Company Ltd.3$49
Boston Scientific2$45
Biomerieux Inc1$45
Nestle Healthcare Nutrition Inc.2$42
Dexcom, Inc.2$31
Vertex1$24
Sumitomo Pharma America, Inc.1$23
Si-bone, Inc.1$22
Globus Medical1$22
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$21
Bausch Health US, LLC1$17
Cequr Corporation1$17
Neurocrine Biosciences, Inc.1$17
Collegium Pharmaceutical, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16
Nevro Corp.1$16
Tris Pharma Inc1$16
Idorsia Pharmaceuticals US Inc1$14
Axsome Therapeutics, Inc.1$14
Upsher-smith Laboratories LLC1$14
Regeneron Healthcare Solutions, Inc.1$14
E.r. Squibb & Sons, L.L.C.1$14
Neos Therapeutics, LP1$13
Shire North American Group Inc1$12
Ironshore Pharmaceuticals Inc.1$12
Zyla Life Sciences, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,884 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$210,049
Medicare patients
504
Services billed
4,751

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban88$96,464
OzempicSemaglutide68$75,745
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$34,568
Repatha SureclickEvolocumab48$28,294
MyrbetriqMirabegron48$24,843
ProliaDenosumab12$20,378
MounjaroTirzepatide19$19,661
FarxigaDapagliflozin Propanediol15$16,861
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$15,096
JardianceEmpagliflozin18$10,902
Emgality PenGalcanezumab-Gnlm16$10,629
PremarinEstrogens, Conjugated25$6,396
LivaloPitavastatin Calcium12$5,408
Rosuvastatin Calcium327$4,720
Levothyroxine Sodium197$3,816

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin, Paxlovid$651$104,289131 claims
Novo NordiskOzempic$1,176$75,74568 claims
GSKTrelegy Ellipta, Shingrix$827$37,50659 claims
AstraZenecaFarxiga, Breztri Aerosphere$475$31,95727 claims
Astellas Pharma US IncMyrbetriq$114$24,84348 claims
AmgenProlia$1,111$20,37812 claims
Lilly USA, LLCMounjaro$579$19,66119 claims
Boehringer IngelheimJardiance$219$10,90218 claims
Kowa Pharmaceuticals America, Inc.Livalo$136$5,40812 claims
AbbVieSynthroid$1,293$3,46563 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Morehead City

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →